Efficacy News and Research

RSS

Climate change anxiety is pushing Americans toward collective climate action

New research reveals that while climate anxiety drives many Americans to take action on climate change, those with severe distress may struggle to engage, highlighting the need for mental health support in the fight against environmental threats.

15 Oct 2024

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease models, while restoring oxytocin levels in both mice and human brain organoids.

14 Oct 2024

New EULAR recommendations provide updated treatment strategies for systemic sclerosis

SSc is a rare connective tissue disorder, with both autoimmune and vascular features. The main hallmark is tissue and vascular fibrosis that can result in clinical heterogeneity of manifestations across the skin and internal organs.

14 Oct 2024

How gut microbiome and fiber diversity shape chronic disease outcomes

Review explores how different types of dietary fibers interact with the gut microbiome, influencing chronic disease risks like obesity, cancer, and cardiometabolic conditions, while emphasizing the need for personalized dietary interventions.

13 Oct 2024

Cycle ergometry reduces ICU stays and improves recovery in critically ill patients

Study found that ICU-based cycle ergometry may reduce the length of ICU and hospital stays while improving physical function without affecting mortality or causing adverse events.

13 Oct 2024

New computational pipeline revolutionizes personalized cancer vaccine design

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence algorithms to use its output to design personalized cancer vaccines for patients.

12 Oct 2024

Promising stool test and therapy on the horizon for endometriosis

Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development of a non-invasive stool test and a new therapy for endometriosis, a painful condition that affects nearly 200 million women worldwide.

12 Oct 2024

Multidisciplinary approach improves quality of life in functional movement disorders

The research team of the Neurology Department Movement Disorders Unit at the Virgen del Rocío University Hospital and the Movement Disorders group of the Institute of Biomedicine of Seville - IBiS, in collaboration with researchers from the Mental Health Clinical Management Unit and the Translational Psychiatry group coordinated by Benedicto Crespo Facorro (HUVR-IBiS/CIBERSAM), has published a randomized clinical trial demonstrating for the first time that a multidisciplinary approach integrating specific physiotherapy and cognitive-behavioral therapy is effective in improving the symptoms and physical aspects of the quality of life of patients with functional movement disorders.

12 Oct 2024

A comprehensive regulatory model to ensure safety and quality of medical devices

Announcing a new article publication for BIO Integration journal. The development of a comprehensive regulatory model for medical devices is essential to ensure the safety, efficacy, and quality of medical devices throughout their lifecycle, from design and development to post-market surveillance.

12 Oct 2024

Innovative nanodiscs offer less invasive method for deep brain stimulation

Novel magnetic nanodiscs could provide a much less invasive way of stimulating parts of the brain, paving the way for stimulation therapies without implants or genetic modification, MIT researchers report.

12 Oct 2024

Harnessing neural networks to forecast treatment outcomes in small cell lung cancer

As immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes has become a focal point in clinical practice. Immunotherapy combined with chemotherapy has been approved as first-line therapy for small cell lung cancer due to its survival benefit in randomized controlled trials.

12 Oct 2024

Integrated HIV prevention strategy increases PrEP adherence among transgender women

Researchers from the HIV Prevention Trials Network (HPTN) presented results from HPTN 091 ("I Am Study") at the HIVR4P 2024 conference in Lima, Peru. The study examined the acceptability and feasibility of an integrated multicomponent strategy to enhance daily oral HIV pre-exposure prophylaxis (PrEP) uptake and adherence among transgender women in a randomized immediate versus deferred design.

12 Oct 2024

New study reveals the power of smile synchronization

Smiling during conversations creates warmth, making people feel more comfortable and connected. For example, a friendly smile when meeting someone new can ease nervousness. A smile can soften tension in a debate, showing respect among the participants despite disagreement.

12 Oct 2024

Skin pigmentation may affect drug efficacy and safety

Skin pigmentation may act as a "sponge" for some medications, potentially influencing the speed with which active drugs reach their intended targets, a pair of scientists report in a perspective article published in the journal Human Genomics.

10 Oct 2024

Study reveals how bacterial selfishness affects antibiotic resistance strategies

As strains of pathogens resistant to frontline antibiotics become more common worldwide, clinicians are more often turning to combination treatments that degrade this resistance as a first treatment option.

10 Oct 2024

Baylor scientist earns NIH grant for personalized microbiome treatments

Baylor University researcher Aaron Wright, Ph.D., has earned a $5.6 million National Institutes of Health (NIH) Director's Transformative Research Award for a project that he and collaborators hope could lead to personalized – and revolutionary – treatments for gut microbiome diseases like Irritable Bowel Syndrome (IBS), Crohn's, Ulcerative Colitis and more.

9 Oct 2024

US study uncovers antiviral resistance in swine-origin influenza, urging enhanced pandemic surveillance

Researchers in the US analyzed swine-origin influenza viruses, identifying key mutations that could reduce antiviral drug effectiveness and threaten pandemic preparedness.

9 Oct 2024

New review explores Zika virus as a potential treatment for brain cancer

A new review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review."

9 Oct 2024

Groundbreaking study challenges treatment protocols for glioblastoma in older adults

A groundbreaking study led by Dr Monika E. Hegi, MD, PhD and European Organisation for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, Dr Thierry Gorlia, PhD) reveals that older adults glioblastoma patients with truly unmethylated MGMT promoter do not benefit from temozolomide (TMZ) treatment, challenging current treatment protocols and paving the way for more personalised therapies.

9 Oct 2024

Gene therapy offers hope for children with cerebral adrenoleukodystrophy

Cerebral adrenoleukodystrophy (CALD) is a rare progressive, genetic brain disease that primarily presents in young boys, causing loss of neurological function and ultimately leading to early death.

9 Oct 2024

Efficacy News and Research

Climate change anxiety is pushing Americans toward collective climate action

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

New EULAR recommendations provide updated treatment strategies for systemic sclerosis

How gut microbiome and fiber diversity shape chronic disease outcomes

Cycle ergometry reduces ICU stays and improves recovery in critically ill patients

New computational pipeline revolutionizes personalized cancer vaccine design

Promising stool test and therapy on the horizon for endometriosis

Multidisciplinary approach improves quality of life in functional movement disorders

A comprehensive regulatory model to ensure safety and quality of medical devices

Innovative nanodiscs offer less invasive method for deep brain stimulation

Harnessing neural networks to forecast treatment outcomes in small cell lung cancer

Integrated HIV prevention strategy increases PrEP adherence among transgender women

New study reveals the power of smile synchronization

Skin pigmentation may affect drug efficacy and safety

Study reveals how bacterial selfishness affects antibiotic resistance strategies

Baylor scientist earns NIH grant for personalized microbiome treatments

US study uncovers antiviral resistance in swine-origin influenza, urging enhanced pandemic surveillance

New review explores Zika virus as a potential treatment for brain cancer

Groundbreaking study challenges treatment protocols for glioblastoma in older adults

Gene therapy offers hope for children with cerebral adrenoleukodystrophy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News